Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 15;19(1):74.
doi: 10.1186/s12902-019-0396-x.

Protocol: investigating the effectiveness and cost benefit of a lifestyle intervention targeting type 2 diabetes in Australia

Linda Cloete  1 , Brett G Mitchell  2 , Darren Morton  3
Affiliations

Protocol: investigating the effectiveness and cost benefit of a lifestyle intervention targeting type 2 diabetes in Australia

Linda Cloete et al. BMC Endocr Disord. .

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) has become an endemic disease. A number of interrelated factors increase the risk of the onset of T2DM, however much of the pathogenesis of the disease is associated with lifestyle. A number of studies have indicated that adopting positive lifestyle changes can successfully prevent or delay the onset of T2DM in a number of different population groups. The CHIP intervention is a lifestyle program that has been shown in over more than 30 published papers have indicated that the CHIP intervention leads to dramatic improvement in the indicators of T2DM these diseases of lifestyle.

Methods: A randomized control trial will be conducted involving 150 individuals with an established diagnosis of T2DM. All participants will continue to receive usual ongoing diabetes care, however, the intervention group (75 individuals) will in addition participate in a 12-week CHIP lifestyle intervention programme followed by a further 9 months of monthly follow-up appointments. Approval for funding was obtained on 30 June 2017.

Discussion: The outcomes of this study have the potential to inform decisions about patient treatment and potentially provide incentive for the provision of funded lifestyle-based preventive and restorative programs for patients diagnosed with T2DM.

Trial registration: This trial is registered as an initial version with the Australia New Zealand Clinical Trials Registry ( http://www.anzctr.org.au/ ), registration number ACTRN12617001233314. Registered on 23/08/2017. No enrollments in the study to date.

Keywords: CHIP; Cost benefit; Diabetes; Lifestyle; Type 2 Diabetes Mellitus.

PubMed Disclaimer

Conflict of interest statement

Funding, as explained below is the only declared potential competing interest. Sanitarium health and well being are the licenced owners of the intervention (CHIP) programme. The authors declare that they have no other competing interests.

Figures

Fig. 1
Fig. 1
An overview of the study design and allocation of participants
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health O. Global report on diabetes. 2017. Report No.: 978 92 4 156525 7 (NLM classification: WK 810).
    1. National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk NICE guidelines [PH38] 2012 [updated 2016. Available from: https://www.nice.org.uk/guidance/ph38/chapter/Recommendations.
    1. Abuyassin B, Laher I. Obesity-linked diabetes in the Arab world: a review. East Mediterr Health J. 2015;21(6):420–439. doi: 10.26719/2015.21.6.420. - DOI - PubMed
    1. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, et al. Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol. 2012;176(11):959–969. doi: 10.1093/aje/kws172. - DOI - PubMed
    1. Cloete L, Mitchell B, Morton D. The role of obesity in the onset of type 2 diabetes mellitus. Nurs Stand. 2017;31(22):59–71. doi: 10.7748/ns.2017.e10672. - DOI - PubMed